Deerfield Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,411,571
| Closed | -$106M | – | 273 |
|
|
2024
Q3 | $106M | Hold |
5,411,571
| – | – | 1.58% | 18 |
|
|
2024
Q2 | $111M | Hold |
5,411,571
| – | – | 1.85% | 14 |
|
|
2024
Q1 | $115M | Buy |
5,411,571
+98,838
| +2% | +$2.11M | 2.01% | 14 |
|
|
2023
Q4 | $76.4M | Buy |
5,312,733
+938,689
| +21% | +$13.5M | 1.41% | 22 |
|
|
2023
Q3 | $39.9M | Buy |
4,374,044
+1,136,044
| +35% | +$10.4M | 0.88% | 30 |
|
|
2023
Q2 | $34.3M | Buy |
3,238,000
+855,000
| +36% | +$9.05M | 0.73% | 34 |
|
|
2023
Q1 | $29.1M | Hold |
2,383,000
| – | – | 0.65% | 41 |
|
|
2022
Q4 | $29.6M | Buy |
2,383,000
+163,872
| +7% | +$2.03M | 0.61% | 48 |
|
|
2022
Q3 | $30.3M | Sell |
2,219,128
-407,872
| -16% | -$5.57M | 0.6% | 52 |
|
|
2022
Q2 | $48.2M | Sell |
2,627,000
-1,789,361
| -41% | -$32.8M | 0.99% | 35 |
|
|
2022
Q1 | $71M | Buy |
4,416,361
+902,605
| +26% | +$14.5M | 1.59% | 23 |
|
|
2021
Q4 | $49.2M | Buy |
3,513,756
+1,198,339
| +52% | +$16.8M | 1.03% | 33 |
|
|
2021
Q3 | $43.4M | Buy |
2,315,417
+521,417
| +29% | +$9.77M | 0.85% | 35 |
|
|
2021
Q2 | $37.4M | Buy |
+1,794,000
| New | +$37.4M | 0.66% | 50 |
|